| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/14/2010 | CA2729317A1 New enzymatic active enzyme against clostridium |
| 01/14/2010 | CA2729306A1 Notch-binding agents and antagonists and methods of use thereof |
| 01/14/2010 | CA2728441A1 Soluble canola protein isolate production ("nutratein") |
| 01/14/2010 | CA2728351A1 Peptidylarginine deiminase (pad) inhibitors |
| 01/14/2010 | CA2727574A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | CA2726945A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 01/13/2010 | EP2143796A2 1983, 52881, 2398, 45449, 50289, and 52872, G protein-coupled receptors and uses therefor |
| 01/13/2010 | EP2143736A1 Hydroxyalkyl starch derivatives |
| 01/13/2010 | EP2143733A1 ANTI-IL-20 antibodies and binding partners and methods of using in inflammation |
| 01/13/2010 | EP2143732A1 T1R1 Taste receptors and genes encoding same |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143730A2 Modified peptides and their use for the treatment of autoimmune diseases |
| 01/13/2010 | EP2143729A1 New enzymatic active enzyme against Clostridium |
| 01/13/2010 | EP2143728A1 Improved process for the preparation of copolymer-1 |
| 01/13/2010 | EP2143442A1 Treatment of solid tumors with tissue inhibitors of metalloproteinases(TIMPs) |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2142931A1 Method for the diagnosis of tuberculosis |
| 01/13/2010 | EP2142564A2 Use gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls) |
| 01/13/2010 | EP2142563A1 Bis-met histones |
| 01/13/2010 | EP2142256A1 Treatment of obesity |
| 01/13/2010 | EP2142217A2 Method for detecting autoprocessed, secreted pcsk9 |
| 01/13/2010 | EP1692162B1 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system |
| 01/13/2010 | EP1537218B1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 01/13/2010 | EP1527087B1 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1360500B1 Methods for selective targeting |
| 01/13/2010 | EP1339744B1 Production of recombinant bmp-2 |
| 01/13/2010 | EP1337627B1 Method for purifying adenoviruses |
| 01/13/2010 | CN101627053A Pan-cell surface receptor- specific therapeutics |
| 01/13/2010 | CN101627052A Proteins activating pro-phenoloxidase system and genes encoding the same |
| 01/13/2010 | CN101627051A Use of polypeptides as coccidiostat and /or histomonastat |
| 01/13/2010 | CN101627050A Avian influenza vaccine |
| 01/13/2010 | CN101624422A Schistosoma japonicum recombinant multi-epitope antigens, method for expressing and purifying same and application thereof |
| 01/13/2010 | CN101624421A Virus-like particle recombinant protein of virus variation strain VP2 gene of infectious bursal disease |
| 01/13/2010 | CN101624420A Group of novel cyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof |
| 01/13/2010 | CN101624419A Group of novel uncyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof |
| 01/13/2010 | CN100580087C Conjugation of peptides |
| 01/13/2010 | CN100580084C Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579986C Production method of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog |
| 01/13/2010 | CN100579985C Streptococcus agalactiae antigens I and II |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2010 | US7647217 Structure of the farnesoid X receptor ligand binding domain and methods of use therefor |
| 01/12/2010 | US7645920 Mutant gene of the GRAS family and plants with reduced development containing said mutant gene |
| 01/12/2010 | US7645919 Controlling gene expression in plants |
| 01/12/2010 | US7645918 Genetic engineering; efficient and stable transformation of plastids |
| 01/12/2010 | US7645867 DNA molecules encoding ligand gated ion channels from Dermacentor variabilis |
| 01/12/2010 | US7645865 System for monitoring the location of transgenes |
| 01/12/2010 | US7645860 Proteinaceous construct comprising a Factor VIII molecule conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII; for prolonging in vivo-half-life of FVIII in the blood of a mammal having a bleeding disorder associated with functional defects or deficiencies of FVIII |
| 01/12/2010 | US7645859 Antitumor polypeptide for example p53; inhibit the pro-apoptotic activity |
| 01/12/2010 | US7645858 synthesis of long peptides (over 20 amino acid residues) or for peptides where synthesis is problematic on 2-chlorotritylchloride resin; first resin is chosen so that it does not lead to the formation of cyclic dipeptides and in particular to the formation of diketopiperazine compounds |
| 01/12/2010 | US7645857 Methods of indentifying modulators of the FGF receptor |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645740 Peptide sequence found in Laminin 5 for treating skin impairments |
| 01/12/2010 | US7645737 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis |
| 01/12/2010 | US7645735 administering to a patient in need of prevention of endometrosis, a therapeutically effective amount of a peptide, consisting of 10 to 35 amino acids of the N-terminal region of a human endostatin protein including the first histidine of the endostatin protein or variant |
| 01/12/2010 | US7645734 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/12/2010 | US7645733 Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 01/12/2010 | US7645588 Human or rodent Stromal Interacting Molecule (STIM) 1 protein; for treatment of diseases associated with calcium dysregulation |
| 01/12/2010 | US7645578 Controlling genetic expression via antisense oligonucleotides and DNA/RNA nuclease digestion; heat resistance; microarrays |
| 01/12/2010 | US7645577 Polypeptides extracellular matrix adhesin (Ema)A, EmaB, EmaC, EmaD and EmaE |
| 01/12/2010 | US7645455 Chimeric lyssavirus nucleic acids and polypeptides |
| 01/12/2010 | US7645454 Prostate specific antigens and uses thereof |
| 01/12/2010 | US7645452 RTVP based compositions and methods for the treatment of prostate cancer |
| 01/12/2010 | US7645451 Treating a subject at risk of a tumor characterized by aberrant Dkk-1 expression using e.g. antibody, antisense agent |
| 01/12/2010 | US7645445 Purified mammalian cytokine IL-174 polypeptides |
| 01/12/2010 | US7645441 Compositions and methods in cancer associated with altered expression of PRLR |
| 01/12/2010 | CA2443365C Methods for the recombinant production of antifusogenic peptides |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2402339C Viral antigen and vaccine against isav (infectious salmon anaemia virus) |
| 01/12/2010 | CA2351558C Peptide fragments having cell death inhibitory activity |
| 01/12/2010 | CA2340974C Method for purifying proteins and/or biomolecule or protein complexes |
| 01/12/2010 | CA2331846C Expression vectors for stimulating an immune response and methods of using the same |
| 01/12/2010 | CA2327266C Pesticidal toxins and nucleotide sequences which encode these toxins |
| 01/12/2010 | CA2300360C Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 01/12/2010 | CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use |
| 01/12/2010 | CA2290217C Peptides for the detection of hiv-1 group o |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/12/2010 | CA2255106C Varicella zoster virus (vzv) immunoreactive protein vp26 and its diagnostic use |
| 01/12/2010 | CA2254954C Morphogen treatment for chronic renal failure |
| 01/12/2010 | CA2170412C Modified plant viruses as vectors of heterologous peptides |
| 01/12/2010 | CA2158782C Marker for growth hormone-releasing factor receptors |
| 01/07/2010 | WO2010003118A1 Tgf-b antagonist multi-target binding proteins |
| 01/07/2010 | WO2010003108A2 TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 01/07/2010 | WO2010003085A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/07/2010 | WO2010003065A2 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | WO2010003032A2 Recombinant human parainfluenza type 1 viruses (hpiv1s) containing mutations in or deletion of the c protein are attenuated in african green monkeys and in ciliated human airway epithelial cells and are potential vaccine candidates for hpiv1 |
| 01/07/2010 | WO2010002583A2 Natriuretic polypeptides with unique pharmacologic profiles |
| 01/07/2010 | WO2010002478A2 Glycopeptide and uses thereof |
| 01/07/2010 | WO2010002468A1 A functional complementation assay for defined gpcr oligomers |
| 01/07/2010 | WO2010002283A2 New insulin analogues of prolonged activity |
| 01/07/2010 | WO2010002277A1 Methods and compositions for improving trees |
| 01/07/2010 | WO2010002276A1 Compositions and methods for improving trees |
| 01/07/2010 | WO2010002251A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | WO2010001414A1 Expression of heterologous proteins in bacterial system using a gm-csf fusion tag |
| 01/07/2010 | WO2010001134A2 Insulin fusion polypeptides |
| 01/07/2010 | WO2010000854A2 New bacteriophage adhesion proteins |
| 01/07/2010 | WO2010000849A2 A method for the screening of conserved secreted proteins |
| 01/07/2010 | WO2010000801A2 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof |